AFT Pharmaceuticals Ltd.'s market cap is currently AU$258.06M. The company's EPS TTM is AU$0.121; its P/E ratio is 23.60; and it has a dividend yield of 0.45%. AFT Pharmaceuticals Ltd. is scheduled to report earnings on May 21, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in NZD
AFT Pharmaceuticals Ltd. Earnings and Revenue History
